Your submission was successfully received!

Clinical studies play an important role in discovering potential new treatment options. By expressing interest in the SYNCHRONY Histology study, you have taken the first step in contributing to the scientific advancement of an investigational drug for people living with non-cirrhotic nonalcoholic steatohepatitis, or NASH/MASH. The entire study team thanks you for submitting your contact information.

What’s Next?

• A member of our study team will contact you by phone in a few business days to discuss your eligibility in more detail.
• We have also sent you a confirmation email for your records.